查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1513409

同種異體肌腱市場：依產品類型、最終用戶分類：2023-2032 年全球機會分析與產業預測

Tendon Allograft Market By Product Type (Achilles Tendon, Tibialis, Patellar Tendon, Others), By End User (Hospitals, Orthopedic Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032
出版日期: | 出版商: Allied Market Research | 英文 280 Pages | 商品交期: 2-3個工作天內

價格
全球同種異體肌腱市場預計將從2022年的264.838億美元成長到2032年的427.139億美元，2023-2032年複合年成長率為5.2%。
同種異體肌腱市場-IMG1
同種異體肌腱移植是一種用屍體捐贈者的肌腱替換受損或撕裂的肌腱的外科手術。同種異體肌腱移植物通常從無菌保存的組織庫中收穫。這種手術通常用於整形外科手術，例如膝關節或肩關節韌帶重組，以恢復受影響關節的功能和穩定性。由於多種因素，同種異體肌腱市場近年來經歷了顯著成長。同種異體肌腱移植物是取自人類捐贈者的移植物，用於整形外科手術以修復或替換受損的肌腱。手術技術和技術的進步使得同種異體肌腱移植手術更加安全有效。微創手術和改進的組織處理降低了併發症的風險並改善了患者的治療效果，從而提高了外科醫生的採用率。隨著人們參與體育運動和體力活動的增加，包括肌腱損傷在內的運動相關損傷也呈現上升趨勢。合成移植物，例如聚對苯二甲酸乙二醇酯 (PET) 和聚醚醚酮 (PEEK)，是同種異體移植物的替代品。這種合成材料具有標準化特性和降低疾病傳播風險等優點，對同種異體肌腱移植物的市場佔有率構成挑戰。使用同種異體肌腱進行 ACL重組和其他手術需要專門的手術技巧和技術。手術結果的變化和潛在的併發症可能會影響外科醫生和醫療機構的接受率。隨著外科醫生對同種異體肌腱移植的表現越來越有信心，他們的適應症正在從 ACL重組擴展到其他整形外科手術，包括肩迴旋肌修復、肩部穩定以及踝關節和腕關節韌帶重組。由於適應症的擴大，同種異體肌腱的市場規模預計將顯著擴大。老齡化社會更容易受到肌肉骨骼損傷和骨關節炎等退化性疾病的影響，這可能需要手術干預，包括肌腱同種異體移植。隨著全球人口老化，對整形外科手術的需求將會增加，並可能推動同種異體肌腱移植市場的成長。再生醫學領域的不斷發展為新型肌腱修復和再生策略的發展提供了充滿希望的機會。本報告介紹的主要企業包括 Aesculap、Lattice Biologics Ltd.、MTF Biologics、LifeNet Health、Integra LifeSciences Corporation、RTI Surgical、Tissue Banks International、AlloSource、Arthrex、Zimmer Biomet Holdings Inc. 等。為了在市場競爭中獲得優勢，各公司充分利用聯盟、收購等策略不斷努力。

相關人員的主要利益

  • 本報告定量分析了 2022 年至 2032 年同種異體肌腱市場的細分市場、當前趨勢、估計趨勢和動態，並確定了同種異體肌腱市場的有前景的機會。
  • 我們提供市場研究以及與市場促進因素、市場限制和市場機會相關的資訊。
  • 波特的五力分析揭示了買家和供應商的潛力，幫助相關人員做出利潤驅動的業務決策並加強供應商和買家網路。
  • 肌腱同種異體移植市場細分的詳細分析將有助於確定市場機會。
  • 每個地區的主要國家都根據其對全球市場的收益貢獻繪製了地圖。
  • 市場參與者定位有助於基準化分析，並提供對市場參與者當前地位的清晰了解。
  • 研究報告包括對區域和全球肌腱同種異體移植市場趨勢、主要企業、細分市場、應用領域和市場成長策略的分析。

目錄

第1章簡介

第 2 章執行摘要

第3章市場概況

  • 市場定義和範圍
  • 主要發現
    • 影響因素
    • 主要投資機會
  • 波特五力分析
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會
  • 平均售價
  • 市場佔有率分析
  • 品牌佔有率分析
  • 貿易資料分析
  • 產品消費
  • 價值鏈分析
  • 主要球員詳細資訊
  • 關鍵監管分析
  • 專利情況
  • 監管指引
  • 贖回場景

第4章同種異體肌腱市場：依產品類型

  • 概述
  • 跟腱
  • 脛骨肌腱
  • 膝腱
  • 其他

第5章同種異體肌腱市場：依最終使用者分類

  • 概述
  • 醫院
  • 整形外科診所
  • 其他

第6章同種異體肌腱市場：依地區

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 其他
  • 拉丁美洲/中東/非洲
    • 巴西
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 其他

第7章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 2022年主要企業定位

第8章 公司簡介

  • Aesculap
  • Lattice Biologics Ltd.
  • MTF Biologics
  • LifeNet Health
  • Integra LifeSciences Corporation
  • RTI Surgical
  • Tissue Banks International
  • AlloSource
  • Arthrex
  • Zimmer Biomet Holdings Inc.
Product Code: A322367
The global tendon allograft market is anticipated to reach $42,713.9 million by 2032, growing from $26,483.8 million in 2022 at a CAGR of 5.2% from 2023 to 2032.
Tendon Allograft Market - IMG1
A tendon allograft is a surgical procedure in which a damaged or injured tendon is replaced with a tendon obtained from a cadaveric donor. The allograft tendon is typically harvested from a tissue bank where it has been preserved through a process of sterilization and storage. This procedure is often used in orthopedic surgeries, such as ligament reconstruction in the knee or shoulder, to restore function and stability to the affected joint.The tendon allograft market has seen significant growth in recent years due to several factors. Tendon allografts are grafts harvested from human donors and used in orthopedic surgeries to repair or replace damaged tendons. Advances in surgical techniques and technologies have made tendon allograft procedures safer and more effective. Minimally invasive procedures and improvements in tissue processing have reduced the risk of complications and improved patient outcomes, driving adoption among surgeons. With the rise in participation in sports and physical activities, there has been a corresponding increase in sports-related injuries, including tendon injuries. Tendon allografts provide an effective solution for repairing damaged tendons in athletes, driving demand in the market.Synthetic grafts, such as those made from materials like polyethylene terephthalate (PET) or polyether ether ketone (PEEK), present alternatives to allografts. These synthetic options may have advantages such as standardized properties and reduced risk of disease transmission, challenging the market share of tendon allografts. ACL reconstruction and other procedures using tendon allografts require specialized surgical skills and techniques. Variability in surgical outcomes and potential complications may affect adoption rates among surgeons and healthcare facilities. These factors are anticipated to restrain the tendon allograft market growth.As surgeons gain confidence in the performance of tendon allografts, the indications for their use may broaden beyond ACL reconstruction to include other orthopedic procedures, such as rotator cuff repair, shoulder stabilization, and ligament reconstructions in the ankle and wrist. This expansion of indications could significantly increase the market size for tendon allografts. The aging population is more prone to musculoskeletal injuries and degenerative conditions, such as osteoarthritis, which may require surgical interventions involving tendon allografts. As the population continues to age globally, there will likely be an increasing demand for orthopedic procedures, driving the growth of the tendon allograft market. The growing field of regenerative medicine offers promising opportunities for the development of novel tendon repair and regeneration strategies. Tendon-derived stem cells, growth factors, and scaffolds could be combined with allografts to enhance tissue healing and regeneration, providing new avenues for product development and market expansion.The key players profiled in this report include Aesculap, Lattice Biologics Ltd., MTF Biologics, LifeNet Health, Integra LifeSciences Corporation, RTI Surgical, Tissue Banks International, AlloSource, Arthrex, and Zimmer Biomet Holdings Inc. The market players are continuously striving to achieve an upper hand in this competitive market using strategies such as collaborations and acquisitions.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the tendon allograft market analysis from 2022 to 2032 to identify the prevailing tendon allograft market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the tendon allograft market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global tendon allograft market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
  • Analysis of raw material in a product (by %)
  • Investment Opportunities
  • Supply Chain Analysis & Vendor Margins
  • Technology Trend Analysis
  • Market share analysis of players by products/segments
  • New Product Development/ Product Matrix of Key Players
  • Regulatory Guidelines
  • Strategic Recommendations
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Criss-cross segment analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)
  • SWOT Analysis

Key Market Segments

By Product Type

  • Tibialis
  • Patellar Tendon
  • Others
  • Achilles Tendon

By End User

  • Hospitals
  • Orthopedic Clinics
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • United Arab Emirates
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Aesculap
    • Lattice Biologics Ltd.
    • MTF Biologics
    • LifeNet Health
    • Integra LifeSciences Corporation
    • RTI Surgical
    • Tissue Banks International
    • AlloSource
    • Arthrex
    • Zimmer Biomet Holdings Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
  • 3.4. Market dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities
  • 3.5. Average Selling Price
  • 3.6. Market Share Analysis
  • 3.7. Brand Share Analysis
  • 3.8. Trade Data Analysis
  • 3.9. Product Consumption
  • 3.10. Value Chain Analysis
  • 3.11. Key Players Details
  • 3.12. Key Regulation Analysis
  • 3.13. Patent Landscape
  • 3.14. Regulatory Guidelines
  • 3.15. Reimbursement Scenario

CHAPTER 4: TENDON ALLOGRAFT MARKET, BY PRODUCT TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Achilles Tendon
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Tibialis
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Patellar Tendon
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country
  • 4.5. Others
    • 4.5.1. Key market trends, growth factors and opportunities
    • 4.5.2. Market size and forecast, by region
    • 4.5.3. Market share analysis by country

CHAPTER 5: TENDON ALLOGRAFT MARKET, BY END USER

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Hospitals
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Orthopedic Clinics
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Others
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country

CHAPTER 6: TENDON ALLOGRAFT MARKET, BY REGION

  • 6.1. Overview
    • 6.1.1. Market size and forecast By Region
  • 6.2. North America
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by Product Type
    • 6.2.3. Market size and forecast, by End User
    • 6.2.4. Market size and forecast, by country
      • 6.2.4.1. U.S.
      • 6.2.4.1.1. Market size and forecast, by Product Type
      • 6.2.4.1.2. Market size and forecast, by End User
      • 6.2.4.2. Canada
      • 6.2.4.2.1. Market size and forecast, by Product Type
      • 6.2.4.2.2. Market size and forecast, by End User
      • 6.2.4.3. Mexico
      • 6.2.4.3.1. Market size and forecast, by Product Type
      • 6.2.4.3.2. Market size and forecast, by End User
  • 6.3. Europe
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by Product Type
    • 6.3.3. Market size and forecast, by End User
    • 6.3.4. Market size and forecast, by country
      • 6.3.4.1. Germany
      • 6.3.4.1.1. Market size and forecast, by Product Type
      • 6.3.4.1.2. Market size and forecast, by End User
      • 6.3.4.2. UK
      • 6.3.4.2.1. Market size and forecast, by Product Type
      • 6.3.4.2.2. Market size and forecast, by End User
      • 6.3.4.3. France
      • 6.3.4.3.1. Market size and forecast, by Product Type
      • 6.3.4.3.2. Market size and forecast, by End User
      • 6.3.4.4. Spain
      • 6.3.4.4.1. Market size and forecast, by Product Type
      • 6.3.4.4.2. Market size and forecast, by End User
      • 6.3.4.5. Italy
      • 6.3.4.5.1. Market size and forecast, by Product Type
      • 6.3.4.5.2. Market size and forecast, by End User
      • 6.3.4.6. Rest of Europe
      • 6.3.4.6.1. Market size and forecast, by Product Type
      • 6.3.4.6.2. Market size and forecast, by End User
  • 6.4. Asia-Pacific
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by Product Type
    • 6.4.3. Market size and forecast, by End User
    • 6.4.4. Market size and forecast, by country
      • 6.4.4.1. China
      • 6.4.4.1.1. Market size and forecast, by Product Type
      • 6.4.4.1.2. Market size and forecast, by End User
      • 6.4.4.2. Japan
      • 6.4.4.2.1. Market size and forecast, by Product Type
      • 6.4.4.2.2. Market size and forecast, by End User
      • 6.4.4.3. India
      • 6.4.4.3.1. Market size and forecast, by Product Type
      • 6.4.4.3.2. Market size and forecast, by End User
      • 6.4.4.4. South Korea
      • 6.4.4.4.1. Market size and forecast, by Product Type
      • 6.4.4.4.2. Market size and forecast, by End User
      • 6.4.4.5. Australia
      • 6.4.4.5.1. Market size and forecast, by Product Type
      • 6.4.4.5.2. Market size and forecast, by End User
      • 6.4.4.6. Rest of Asia-Pacific
      • 6.4.4.6.1. Market size and forecast, by Product Type
      • 6.4.4.6.2. Market size and forecast, by End User
  • 6.5. LAMEA
    • 6.5.1. Key market trends, growth factors and opportunities
    • 6.5.2. Market size and forecast, by Product Type
    • 6.5.3. Market size and forecast, by End User
    • 6.5.4. Market size and forecast, by country
      • 6.5.4.1. Brazil
      • 6.5.4.1.1. Market size and forecast, by Product Type
      • 6.5.4.1.2. Market size and forecast, by End User
      • 6.5.4.2. Saudi Arabia
      • 6.5.4.2.1. Market size and forecast, by Product Type
      • 6.5.4.2.2. Market size and forecast, by End User
      • 6.5.4.3. United Arab Emirates
      • 6.5.4.3.1. Market size and forecast, by Product Type
      • 6.5.4.3.2. Market size and forecast, by End User
      • 6.5.4.4. South Africa
      • 6.5.4.4.1. Market size and forecast, by Product Type
      • 6.5.4.4.2. Market size and forecast, by End User
      • 6.5.4.5. Rest of LAMEA
      • 6.5.4.5.1. Market size and forecast, by Product Type
      • 6.5.4.5.2. Market size and forecast, by End User

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top winning strategies
  • 7.3. Product mapping of top 10 player
  • 7.4. Competitive dashboard
  • 7.5. Competitive heatmap
  • 7.6. Top player positioning, 2022

CHAPTER 8: COMPANY PROFILES

  • 8.1. Aesculap
    • 8.1.1. Company overview
    • 8.1.2. Key executives
    • 8.1.3. Company snapshot
    • 8.1.4. Operating business segments
    • 8.1.5. Product portfolio
    • 8.1.6. Business performance
    • 8.1.7. Key strategic moves and developments
  • 8.2. Lattice Biologics Ltd.
    • 8.2.1. Company overview
    • 8.2.2. Key executives
    • 8.2.3. Company snapshot
    • 8.2.4. Operating business segments
    • 8.2.5. Product portfolio
    • 8.2.6. Business performance
    • 8.2.7. Key strategic moves and developments
  • 8.3. MTF Biologics
    • 8.3.1. Company overview
    • 8.3.2. Key executives
    • 8.3.3. Company snapshot
    • 8.3.4. Operating business segments
    • 8.3.5. Product portfolio
    • 8.3.6. Business performance
    • 8.3.7. Key strategic moves and developments
  • 8.4. LifeNet Health
    • 8.4.1. Company overview
    • 8.4.2. Key executives
    • 8.4.3. Company snapshot
    • 8.4.4. Operating business segments
    • 8.4.5. Product portfolio
    • 8.4.6. Business performance
    • 8.4.7. Key strategic moves and developments
  • 8.5. Integra LifeSciences Corporation
    • 8.5.1. Company overview
    • 8.5.2. Key executives
    • 8.5.3. Company snapshot
    • 8.5.4. Operating business segments
    • 8.5.5. Product portfolio
    • 8.5.6. Business performance
    • 8.5.7. Key strategic moves and developments
  • 8.6. RTI Surgical
    • 8.6.1. Company overview
    • 8.6.2. Key executives
    • 8.6.3. Company snapshot
    • 8.6.4. Operating business segments
    • 8.6.5. Product portfolio
    • 8.6.6. Business performance
    • 8.6.7. Key strategic moves and developments
  • 8.7. Tissue Banks International
    • 8.7.1. Company overview
    • 8.7.2. Key executives
    • 8.7.3. Company snapshot
    • 8.7.4. Operating business segments
    • 8.7.5. Product portfolio
    • 8.7.6. Business performance
    • 8.7.7. Key strategic moves and developments
  • 8.8. AlloSource
    • 8.8.1. Company overview
    • 8.8.2. Key executives
    • 8.8.3. Company snapshot
    • 8.8.4. Operating business segments
    • 8.8.5. Product portfolio
    • 8.8.6. Business performance
    • 8.8.7. Key strategic moves and developments
  • 8.9. Arthrex
    • 8.9.1. Company overview
    • 8.9.2. Key executives
    • 8.9.3. Company snapshot
    • 8.9.4. Operating business segments
    • 8.9.5. Product portfolio
    • 8.9.6. Business performance
    • 8.9.7. Key strategic moves and developments
  • 8.10. Zimmer Biomet Holdings Inc.
    • 8.10.1. Company overview
    • 8.10.2. Key executives
    • 8.10.3. Company snapshot
    • 8.10.4. Operating business segments
    • 8.10.5. Product portfolio
    • 8.10.6. Business performance
    • 8.10.7. Key strategic moves and developments

LIST OF TABLES

  • TABLE 01. GLOBAL TENDON ALLOGRAFT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 02. TENDON ALLOGRAFT MARKET FOR ACHILLES TENDON, BY REGION, 2022-2032 ($MILLION)
  • TABLE 03. TENDON ALLOGRAFT MARKET FOR TIBIALIS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 04. TENDON ALLOGRAFT MARKET FOR PATELLAR TENDON, BY REGION, 2022-2032 ($MILLION)
  • TABLE 05. TENDON ALLOGRAFT MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 06. GLOBAL TENDON ALLOGRAFT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 07. TENDON ALLOGRAFT MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 08. TENDON ALLOGRAFT MARKET FOR ORTHOPEDIC CLINICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 09. TENDON ALLOGRAFT MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. TENDON ALLOGRAFT MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. NORTH AMERICA TENDON ALLOGRAFT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 12. NORTH AMERICA TENDON ALLOGRAFT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 13. NORTH AMERICA TENDON ALLOGRAFT MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 14. U.S. TENDON ALLOGRAFT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 15. U.S. TENDON ALLOGRAFT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 16. CANADA TENDON ALLOGRAFT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 17. CANADA TENDON ALLOGRAFT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 18. MEXICO TENDON ALLOGRAFT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 19. MEXICO TENDON ALLOGRAFT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 20. EUROPE TENDON ALLOGRAFT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 21. EUROPE TENDON ALLOGRAFT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 22. EUROPE TENDON ALLOGRAFT MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 23. GERMANY TENDON ALLOGRAFT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 24. GERMANY TENDON ALLOGRAFT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 25. UK TENDON ALLOGRAFT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 26. UK TENDON ALLOGRAFT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 27. FRANCE TENDON ALLOGRAFT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 28. FRANCE TENDON ALLOGRAFT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 29. SPAIN TENDON ALLOGRAFT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 30. SPAIN TENDON ALLOGRAFT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 31. ITALY TENDON ALLOGRAFT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 32. ITALY TENDON ALLOGRAFT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 33. REST OF EUROPE TENDON ALLOGRAFT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 34. REST OF EUROPE TENDON ALLOGRAFT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 35. ASIA-PACIFIC TENDON ALLOGRAFT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 36. ASIA-PACIFIC TENDON ALLOGRAFT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 37. ASIA-PACIFIC TENDON ALLOGRAFT MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 38. CHINA TENDON ALLOGRAFT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 39. CHINA TENDON ALLOGRAFT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 40. JAPAN TENDON ALLOGRAFT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 41. JAPAN TENDON ALLOGRAFT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 42. INDIA TENDON ALLOGRAFT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 43. INDIA TENDON ALLOGRAFT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 44. SOUTH KOREA TENDON ALLOGRAFT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 45. SOUTH KOREA TENDON ALLOGRAFT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 46. AUSTRALIA TENDON ALLOGRAFT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 47. AUSTRALIA TENDON ALLOGRAFT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 48. REST OF ASIA-PACIFIC TENDON ALLOGRAFT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 49. REST OF ASIA-PACIFIC TENDON ALLOGRAFT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 50. LAMEA TENDON ALLOGRAFT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 51. LAMEA TENDON ALLOGRAFT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 52. LAMEA TENDON ALLOGRAFT MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 53. BRAZIL TENDON ALLOGRAFT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 54. BRAZIL TENDON ALLOGRAFT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 55. SAUDI ARABIA TENDON ALLOGRAFT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 56. SAUDI ARABIA TENDON ALLOGRAFT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 57. UNITED ARAB EMIRATES TENDON ALLOGRAFT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 58. UNITED ARAB EMIRATES TENDON ALLOGRAFT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 59. SOUTH AFRICA TENDON ALLOGRAFT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 60. SOUTH AFRICA TENDON ALLOGRAFT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 61. REST OF LAMEA TENDON ALLOGRAFT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 62. REST OF LAMEA TENDON ALLOGRAFT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 63. AESCULAP: KEY EXECUTIVES
  • TABLE 64. AESCULAP: COMPANY SNAPSHOT
  • TABLE 65. AESCULAP: PRODUCT SEGMENTS
  • TABLE 66. AESCULAP: SERVICE SEGMENTS
  • TABLE 67. AESCULAP: PRODUCT PORTFOLIO
  • TABLE 68. AESCULAP: KEY STRATEGIES
  • TABLE 69. LATTICE BIOLOGICS LTD.: KEY EXECUTIVES
  • TABLE 70. LATTICE BIOLOGICS LTD.: COMPANY SNAPSHOT
  • TABLE 71. LATTICE BIOLOGICS LTD.: PRODUCT SEGMENTS
  • TABLE 72. LATTICE BIOLOGICS LTD.: SERVICE SEGMENTS
  • TABLE 73. LATTICE BIOLOGICS LTD.: PRODUCT PORTFOLIO
  • TABLE 74. LATTICE BIOLOGICS LTD.: KEY STRATEGIES
  • TABLE 75. MTF BIOLOGICS: KEY EXECUTIVES
  • TABLE 76. MTF BIOLOGICS: COMPANY SNAPSHOT
  • TABLE 77. MTF BIOLOGICS: PRODUCT SEGMENTS
  • TABLE 78. MTF BIOLOGICS: SERVICE SEGMENTS
  • TABLE 79. MTF BIOLOGICS: PRODUCT PORTFOLIO
  • TABLE 80. MTF BIOLOGICS: KEY STRATEGIES
  • TABLE 81. LIFENET HEALTH: KEY EXECUTIVES
  • TABLE 82. LIFENET HEALTH: COMPANY SNAPSHOT
  • TABLE 83. LIFENET HEALTH: PRODUCT SEGMENTS
  • TABLE 84. LIFENET HEALTH: SERVICE SEGMENTS
  • TABLE 85. LIFENET HEALTH: PRODUCT PORTFOLIO
  • TABLE 86. LIFENET HEALTH: KEY STRATEGIES
  • TABLE 87. INTEGRA LIFESCIENCES CORPORATION: KEY EXECUTIVES
  • TABLE 88. INTEGRA LIFESCIENCES CORPORATION: COMPANY SNAPSHOT
  • TABLE 89. INTEGRA LIFESCIENCES CORPORATION: PRODUCT SEGMENTS
  • TABLE 90. INTEGRA LIFESCIENCES CORPORATION: SERVICE SEGMENTS
  • TABLE 91. INTEGRA LIFESCIENCES CORPORATION: PRODUCT PORTFOLIO
  • TABLE 92. INTEGRA LIFESCIENCES CORPORATION: KEY STRATEGIES
  • TABLE 93. RTI SURGICAL: KEY EXECUTIVES
  • TABLE 94. RTI SURGICAL: COMPANY SNAPSHOT
  • TABLE 95. RTI SURGICAL: PRODUCT SEGMENTS
  • TABLE 96. RTI SURGICAL: SERVICE SEGMENTS
  • TABLE 97. RTI SURGICAL: PRODUCT PORTFOLIO
  • TABLE 98. RTI SURGICAL: KEY STRATEGIES
  • TABLE 99. TISSUE BANKS INTERNATIONAL: KEY EXECUTIVES
  • TABLE 100. TISSUE BANKS INTERNATIONAL: COMPANY SNAPSHOT
  • TABLE 101. TISSUE BANKS INTERNATIONAL: PRODUCT SEGMENTS
  • TABLE 102. TISSUE BANKS INTERNATIONAL: SERVICE SEGMENTS
  • TABLE 103. TISSUE BANKS INTERNATIONAL: PRODUCT PORTFOLIO
  • TABLE 104. TISSUE BANKS INTERNATIONAL: KEY STRATEGIES
  • TABLE 105. ALLOSOURCE: KEY EXECUTIVES
  • TABLE 106. ALLOSOURCE: COMPANY SNAPSHOT
  • TABLE 107. ALLOSOURCE: PRODUCT SEGMENTS
  • TABLE 108. ALLOSOURCE: SERVICE SEGMENTS
  • TABLE 109. ALLOSOURCE: PRODUCT PORTFOLIO
  • TABLE 110. ALLOSOURCE: KEY STRATEGIES
  • TABLE 111. ARTHREX: KEY EXECUTIVES
  • TABLE 112. ARTHREX: COMPANY SNAPSHOT
  • TABLE 113. ARTHREX: PRODUCT SEGMENTS
  • TABLE 114. ARTHREX: SERVICE SEGMENTS
  • TABLE 115. ARTHREX: PRODUCT PORTFOLIO
  • TABLE 116. ARTHREX: KEY STRATEGIES
  • TABLE 117. ZIMMER BIOMET HOLDINGS INC.: KEY EXECUTIVES
  • TABLE 118. ZIMMER BIOMET HOLDINGS INC.: COMPANY SNAPSHOT
  • TABLE 119. ZIMMER BIOMET HOLDINGS INC.: PRODUCT SEGMENTS
  • TABLE 120. ZIMMER BIOMET HOLDINGS INC.: SERVICE SEGMENTS
  • TABLE 121. ZIMMER BIOMET HOLDINGS INC.: PRODUCT PORTFOLIO
  • TABLE 122. ZIMMER BIOMET HOLDINGS INC.: KEY STRATEGIES

LIST OF FIGURES

  • FIGURE 01. TENDON ALLOGRAFT MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF TENDON ALLOGRAFT MARKET,2022-2032
  • FIGURE 03. TOP IMPACTING FACTORS IN TENDON ALLOGRAFT MARKET
  • FIGURE 04. TOP INVESTMENT POCKETS IN TENDON ALLOGRAFT MARKET (2023-2032)
  • FIGURE 05. BARGAINING POWER OF SUPPLIERS
  • FIGURE 06. BARGAINING POWER OF BUYERS
  • FIGURE 07. THREAT OF SUBSTITUTION
  • FIGURE 08. THREAT OF SUBSTITUTION
  • FIGURE 09. COMPETITIVE RIVALRY
  • FIGURE 10. GLOBAL TENDON ALLOGRAFT MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. IMPACT OF KEY REGULATION: TENDON ALLOGRAFT MARKET
  • FIGURE 12. PATENT ANALYSIS BY COMPANY
  • FIGURE 13. PATENT ANALYSIS BY COUNTRY
  • FIGURE 14. TENDON ALLOGRAFT MARKET, BY PRODUCT TYPE, 2022 AND 2032(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF TENDON ALLOGRAFT MARKET FOR ACHILLES TENDON, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF TENDON ALLOGRAFT MARKET FOR TIBIALIS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF TENDON ALLOGRAFT MARKET FOR PATELLAR TENDON, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF TENDON ALLOGRAFT MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 19. TENDON ALLOGRAFT MARKET, BY END USER, 2022 AND 2032(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF TENDON ALLOGRAFT MARKET FOR HOSPITALS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF TENDON ALLOGRAFT MARKET FOR ORTHOPEDIC CLINICS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF TENDON ALLOGRAFT MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 23. TENDON ALLOGRAFT MARKET BY REGION, 2022 AND 2032(%)
  • FIGURE 24. U.S. TENDON ALLOGRAFT MARKET, 2022-2032 ($MILLION)
  • FIGURE 25. CANADA TENDON ALLOGRAFT MARKET, 2022-2032 ($MILLION)
  • FIGURE 26. MEXICO TENDON ALLOGRAFT MARKET, 2022-2032 ($MILLION)
  • FIGURE 27. GERMANY TENDON ALLOGRAFT MARKET, 2022-2032 ($MILLION)
  • FIGURE 28. UK TENDON ALLOGRAFT MARKET, 2022-2032 ($MILLION)
  • FIGURE 29. FRANCE TENDON ALLOGRAFT MARKET, 2022-2032 ($MILLION)
  • FIGURE 30. SPAIN TENDON ALLOGRAFT MARKET, 2022-2032 ($MILLION)
  • FIGURE 31. ITALY TENDON ALLOGRAFT MARKET, 2022-2032 ($MILLION)
  • FIGURE 32. REST OF EUROPE TENDON ALLOGRAFT MARKET, 2022-2032 ($MILLION)
  • FIGURE 33. CHINA TENDON ALLOGRAFT MARKET, 2022-2032 ($MILLION)
  • FIGURE 34. JAPAN TENDON ALLOGRAFT MARKET, 2022-2032 ($MILLION)
  • FIGURE 35. INDIA TENDON ALLOGRAFT MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. SOUTH KOREA TENDON ALLOGRAFT MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. AUSTRALIA TENDON ALLOGRAFT MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. REST OF ASIA-PACIFIC TENDON ALLOGRAFT MARKET, 2022-2032 ($MILLION)
  • FIGURE 39. BRAZIL TENDON ALLOGRAFT MARKET, 2022-2032 ($MILLION)
  • FIGURE 40. SAUDI ARABIA TENDON ALLOGRAFT MARKET, 2022-2032 ($MILLION)
  • FIGURE 41. UNITED ARAB EMIRATES TENDON ALLOGRAFT MARKET, 2022-2032 ($MILLION)
  • FIGURE 42. SOUTH AFRICA TENDON ALLOGRAFT MARKET, 2022-2032 ($MILLION)
  • FIGURE 43. REST OF LAMEA TENDON ALLOGRAFT MARKET, 2022-2032 ($MILLION)
  • FIGURE 44. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 45. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 46. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 47. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 48. COMPETITIVE DASHBOARD
  • FIGURE 49. COMPETITIVE HEATMAP: TENDON ALLOGRAFT MARKET
  • FIGURE 50. TOP PLAYER POSITIONING, 2022